Research today. Impact tomorrow.

25% Off the entire catalogue →

Same standards. Greater possibilities.

Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

Cognitive & neurological research

Adamax: Research Overview

Modified Semax derivative studied in cognition and neuroprotection research.

Research use onlyStrongest evidence: animal studyReviewed
DatabaseReferences

What is Adamax?

Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement, neuroprotection, and neuroplasticity.

What is Adamax researched for?

  • Preliminary research suggests improvements in focus, mental clarity, memory consolidation, and complex task handling.
  • BDNF upregulation and TrkB enhancement promote new neural connections and synaptic plasticity for long-term improvements.
  • May enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.
  • Preliminary observations indicate improved neurological outcomes through oxidative stress reduction and neuronal repair.
  • Demonstrates antioxidant properties protecting against oxidative damage and inflammation-induced neuronal injury.
  • Supports neuronal survival and growth through BDNF enhancement and microtubule stabilization.
  • Influences serotonin and dopamine to elevate mood and reduce depressive symptoms through neurotransmitter modulation.
  • Anecdotal reports indicate reduced overwhelm and anxiety through balanced neurotransmitter activity.
  • HPA axis modulation may improve stress response and emotional well-being.

How does Adamax work?

Crosses BBB via enhanced lipophilicity from adamantane; upregulates BDNF and TrkB receptor sensitivity; modulates dopamine, norepinephrine, and serotonin; stabilizes microtubules via ADNP-derived mechanisms; provides antioxidant and anti-inflammatory neuroprotection.

Reported targets: TrkB

References

  1. A Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound) Ashmarin IP, Nezavibatko VN, Levitskaya NG, et al. Zhurnal Vysshei Nervnoi Deiatelnosti imeni I.P. Pavlova

    1997

    Foundational Semax review: intranasal doses stimulate operative memory and attention for 20-24 hours. Adamax builds on the Semax core sequence with adamantane modification for enhanced stability and BBB penetration.

  2. Semax, an Analog of ACTH(4-10), Regulates BDNF and trkB Expression in the Rat Hippocampus (Parent Compound)

    Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain Research · 2006

    Single application at 50 mcg/kg produced 1.4-fold increase in BDNF protein and 1.6-fold increase in trkB tyrosine phosphorylation in rat hippocampus, supporting Adamax's BDNF-TrkB mechanism.

    Animal study

  3. The Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound) Gusev EI, Barskov IV, et al. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

    2018

    110 ischemic stroke patients; Semax (6000 mcg/day intranasal) increased BDNF plasma levels and accelerated functional recovery, providing the clinical basis for Adamax neuroprotective applications.

  4. The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound) Dergunova LV, Limborska SA, et al. BMC Genomics

    2014

    Genome-wide analysis: Semax modulated 24 vascular genes at 3h and enhanced immune-response gene expression at 24h post-ischemia, demonstrating multi-pathway neuroprotection.

    Animal study

  5. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

    Gusev EI, Martynov MY, Kostenko EV, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018

    PMID 29798983

  6. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

    Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain research · 2006

    Animal study · PMID 16996037

  7. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis

    Medvedeva EV, Dmitrieva VG, Povarova OV, et al. · BMC genomics · 2014

    Animal study · PMID 24661604

  8. [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]

    Asmarin IP, Nezavibat'ko VN, Miasoedov NF, et al. · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 1997

    PMID 9173745

Common questions

How does Adamax improve cognition differently than Semax?

Adamax is a next-generation Semax derivative with C-terminal adamantane modification for enhanced lipophilicity and blood-brain barrier penetration. While parent Semax shows cognitive benefits, Adamax's superior stability and BBB crossing potentially enable stronger cognitive effects at lower doses and with more sustained action.

What causes the headaches some people report on Adamax?

Headaches are most common at higher doses (particularly above 300mcg). This likely relates to the potent dopamine, norepinephrine, and serotonin modulation combined with BDNF upregulation creating temporary neurochemical shifts. Starting at 100-200mcg and titrating slowly minimizes this risk.